Navigation Links
Dow AgroSciences Receives Approval for Cultivation of HERCULEX(R) I Corn in Brazil
Date:1/28/2009

INDIANAPOLIS and SAO PAULO, Brazil, Jan. 28 /PRNewswire-FirstCall/ -- The Brazilian Ministry of Agriculture has authorized Dow AgroSciences to sell its first corn hybrids with HERCULEX(R) I Insect Protection technology. This authorization was given for 2B710HX, 2B688HX, 2B707HX, 2C520HX and 2A525HX corn hybrids. Dow AgroSciences also announced that it plans to be able to offer the Brazilian market its full range of corn hybrids with this technology in the future.

"This is a key milestone that will make available the best corn seed technology to the Brazilian producer and will set a new standard for insect protection in Brazil," said Jerome Peribere, president and CEO, Dow AgroSciences.

HERCULEX I, approved in Brazil in December 2008 by the National Technical Commission of Biosafety (CTNBio), has been in use in the United States, Argentina and other countries for a number of years. The technology provides effective control of important corn pests by incorporating into the plant the cry1F gene, originated from the Bacillus thuringiensis (Bt) microorganism that naturally occurs in the soil.

HERCULEX I protects the corn plant against the Spodoptora frugiperda caterpillar, the main corn pest in Brazil. This protection is extended to the entire life cycle of the plant. It also allows the control of Diatraea saccharalis. Depending upon growing conditions, these pests may cause yield losses of more 40 percent.

With this technology, Brazilian growers should benefit with higher yield, better quality grain, and a new and effective tool to use as part of an integrated pest management system.

About Dow AgroSciences

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $3.8 billion. Learn more at www.dowagro.com

(R)HERCULEX is a trademark of Dow AgroSciences LLC

HERCULEX Insect Protection technology developed by Dow AgroSciences and Pioneer Hi-Bred International


'/>"/>
SOURCE Dow AgroSciences LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. Dow AgroSciences Success Presented to Wall Street
3. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
4. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
5. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
6. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
9. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
10. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
11. IsoTis Receives FDA Clearance for Accell Family of Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
(Date:6/23/2016)... India , June 23, 2016 ... media market research report to its pharmaceuticals section ... profiles, product details and much more. ... spread across 151 pages, profiling 15 companies and ... available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
Breaking Biology Technology:
(Date:6/27/2016)... June 27, 2016 Research and Markets has ... 2016-2020" report to their offering. ... America to grow at a CAGR of 12.28% during ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
(Date:6/22/2016)... 22, 2016   Acuant , the ... solutions, has partnered with RightCrowd ® ... Visitor Management, Self-Service Kiosks and Continuous Workforce ... add functional enhancements to existing physical access ... venues with an automated ID verification and ...
Breaking Biology News(10 mins):